Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESCUE: Renal Safety of Dotarem in High-Risk Patients
NCT00650845Phase 4Completed
- Sponsor
- Guerbet
- Start
- Jan 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of gadoterate meglumine, sponsored by Guerbet. Started Jan 2008; status: completed.
02
Drugs
gadoterate meglumine
Beyond the preview
Go deeper on NCT00650845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00650845.